Related Experiment Videos

A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use

A P Coatesworth1, S J Darnton, R M Green

  • 1Department of Thoracic Surgery, Birmingham Heartlands Hospital, UK.

Insights

Prolonged penicillamine treatment for Wilson's disease may induce systemic pseudo-pseudoxanthoma elasticum, affecting elastic fibers. Switching medication resolved symptoms, suggesting a drug-induced etiology rather than inherited disease.

Area of Science:

  • Medical Genetics
  • Dermatology
  • Gastroenterology

Background:

  • Wilson's disease is a genetic disorder of copper metabolism.
  • Penicillamine is a chelating agent used to treat Wilson's disease.
  • Cutaneous and systemic manifestations can occur in Wilson's disease.

Observation:

  • A 47-year-old man with Wilson's disease on long-term penicillamine presented with dysphagia, dyspnoea, and skin changes.
  • Biopsies confirmed systemic abnormalities in elastic fibers.
  • Symptoms improved after cricopharyngeal myotomy and switching to trientene dihydrochloride.

Findings:

  • This case suggests a potential association between prolonged penicillamine use and acquired pseudo-pseudoxanthoma elasticum.
  • Abnormal elastic fibers, confirmed histologically, likely caused the patient's symptoms.
  • The findings indicate a drug-induced condition rather than idiopathic inherited pseudo-pseudoxanthoma elasticum.

Implications:

  • Highlights a rare adverse effect of penicillamine therapy.
  • Suggests considering drug-induced elastopathy in patients with connective tissue abnormalities.
  • Informs differential diagnosis for dysphagia and dyspnoea in patients with Wilson's disease on penicillamine.

Related Concept Videos